DXCM Jereme M Sylvain sells $845K worth of shares
Mar 15, 2025, 4:32 AM
0.00%
What does DXCM do
DexCom, headquartered in San Diego, develops glucose monitoring systems for diabetes management, employing 9,600 people since its IPO in 2005. Its products include the Dexcom G6 and G7 continuous glucose monitoring systems.
Jereme M Sylvain sold 12,001 shares of DXCM on 12 March at $70.38 per share, worth a total of $845K. They now own 123,481 DXCM shares, or a 9% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.